-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BNcfvreUtD+01crG68z0fnyxi8getrM/8bNwRzMdBsZ0KtQDqwuAYJD/rNGCbKti dbuO4SH4oroT6HgHSdFTvA== 0001179110-10-003917.txt : 20100226 0001179110-10-003917.hdr.sgml : 20100226 20100226164152 ACCESSION NUMBER: 0001179110-10-003917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100225 FILED AS OF DATE: 20100226 DATE AS OF CHANGE: 20100226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cleveland Paul B CENTRAL INDEX KEY: 0001376797 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33213 FILM NUMBER: 10640003 MAIL ADDRESS: STREET 1: C/O AFFYMAX, INC. STREET 2: 4001 MIRANDA AVE. CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AFFYMAX INC CENTRAL INDEX KEY: 0001158223 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4001 MIRANDA AVE CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-812-8700 MAIL ADDRESS: STREET 1: 4001 MIRANDA AVE. CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 edgar.xml FORM 4 - X0303 4 2010-02-25 0 0001158223 AFFYMAX INC AFFY 0001376797 Cleveland Paul B C/O AFFYMAX, INC. 4001 MIRANDA AVE. PALO ALTO CA 94304 0 1 0 0 EVP, Corp. Development and CFO Common Stock 2010-02-25 4 M 0 52935 4.36 A 55935 D Common Stock 2010-02-25 4 S 0 52761 18.29 D 3174 D Common Stock 2010-02-25 4 S 0 3089 19.02 D 85 D Common Stock 2010-02-25 4 S 0 85 19.15 D 0 D Stock Option (Right to Buy) 4.36 2010-02-25 4 M 0 52935 0.00 D 2016-02-06 Common Stock 52935 59837 D Includes shares acquired pursuant to the issuer's employee stock purchase plan. Shares were sold pursuant to a 10b5-1 plan. The shares were sold at prices between $17.98 and $18.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each price. The shares subject to the option are exercisable upon grant. Twenty-Five Percent of the shares subject to the option vest one year from the date of grant and the remainder vest in equal monthly installments over the following three years. /s/ Grace Shin, Attorney-in-Fact 2010-02-26 -----END PRIVACY-ENHANCED MESSAGE-----